{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:55:45Z","timestamp":1765356945947,"version":"3.40.5"},"reference-count":59,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CBIO"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>In the rational drug development field, bioisosterism is a tool that improves lead compounds' performance, referring to molecular fragment substitution that has similar physical-chemical properties. Thus, it is possible to modulate drug properties such as absorption, toxicity, and half-life increase. This modulation is of pivotal importance in the discovery, development, identification, and interpretation of the mode of action of biologically active compounds.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>Our purpose here is to review the development and application of bioisosterism in drug discovery. In this study history, applications, and use of bioisosteric molecules to create new drugs with high binding affinity in the protein-ligand complexes are described.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method:<\/jats:title><jats:p>It is an approach for molecular modification of a prototype based on the replacement of molecular fragments with similar physicochemical properties, being related to the pharmacokinetic and pharmacodynamic phase, aiming at the optimization of the molecules.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Discovery, development, identification, and interpretation of the mode of action of biologically active compounds are the most important factors for drug design. The strategy adopted for the improvement of leading compounds is bioisosterism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Bioisosterism methodology is a great advance for obtaining new analogs to existing drugs, enabling the development of new drugs with reduced toxicity, in a comparative analysis with existing drugs. Bioisosterism has a wide spectrum to assist in several research areas.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1574893616666210525150747","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T10:56:59Z","timestamp":1622026619000},"page":"19-30","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Bioinformatics Approach on Bioisosterism Softwares to be Used in Drug Discovery and Development"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9257-7322","authenticated-orcid":true,"given":"Nelson Jos\u00e9 Freitas","family":"da Silveira","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Modeling and Computer Simulation, Department of Exact Science, Federal University of Alfenas\/UNIFAL-MG, Alfenas, Brazil"}]},{"given":"Walter Filgueira","family":"de Azevedo","sequence":"additional","affiliation":[{"name":"Laboratory of Computational Systems Biology, School of Health and Life Sciences, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, Brazil"}]},{"given":"Rita Cardoso","family":"Guedes","sequence":"additional","affiliation":[{"name":"The Research Institute for Medicines (iMed.Ulisboa) and Department of Pharmaceutical Chemistry and Therapeutics, Faculty of Pharmacy, University of Lisbon, Lisboa, Portugal"}]},{"given":"Leandro Marcos","family":"Santos","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Modeling and Computer Simulation, Department of Exact Science, Federal University of Alfenas\/UNIFAL-MG, Alfenas, Brazil"}]},{"given":"Rodolfo Cabral","family":"Marcelino","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Modeling and Computer Simulation, Department of Exact Science, Federal University of Alfenas\/UNIFAL-MG, Alfenas, Brazil"}]},{"given":"Patr\u00edcia","family":"da Silva Antunes","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Modeling and Computer Simulation, Department of Exact Science, Federal University of Alfenas\/UNIFAL-MG, Alfenas, Brazil"}]},{"given":"Thiago Castilho","family":"Elias","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Modeling and Computer Simulation, Department of Exact Science, Federal University of Alfenas\/UNIFAL-MG, Alfenas, Brazil"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.2174\/1568026617666170403113541","volume":"17","author":"Srivastava P.","year":"2017","unstructured":"Srivastava P.; Tiwari A.; Critical role of computer simulations in drug discovery and development. Curr Top Med Chem 2017,17(21),2422-2432","journal-title":"Curr Top Med Chem"},{"key":"ref=2","first-page":"1","volume":"14","author":"Freitas P.G.","year":"2017","unstructured":"Freitas P.G.; Elias T.C.; Pinto I.A.; Computational approach to the discovery of phytochemical molecules with therapeutic potential targets to the PKCZ protein. Lett Drug Des Discov 2017,14,1-12","journal-title":"Lett Drug Des Discov"},{"key":"ref=3","first-page":"85","volume":"Vol. 1520","author":"Yu W.","year":"2017","unstructured":"Yu W.; Mackerell A.D.J.; Computer-Aided Drug Design Methods Methods in Molecular Biology 2017,Vol. 1520,85-106","journal-title":"Computer-Aided Drug Design Methods Methods in Molecular Biology"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/minf.201501037","volume":"35","author":"Moretti L.","year":"2016","unstructured":"Moretti L.; Sartori L.; Software infrastructure for computer-aided drug discovery and development, a practical example with guidelines. Mol Inform 2016,35(8-9),382-390","journal-title":"Mol Inform"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.4155\/fmc-2018-0252","volume":"10","author":"Wang Y.","year":"2018","unstructured":"Wang Y.; Du Y.; Huang N.; A survey of the role of nitrile groups in protein-ligand interactions. Future Med Chem 2018,10(23),2713-2728","journal-title":"Future Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1007\/s11033-019-04792-w","volume":"46","author":"Nagarajan N.","year":"2019","unstructured":"Nagarajan N.; Yapp E.K.Y.; Le N.Q.K.; Yeh H.Y.; In silico screening of sugar alcohol compounds to inhibit viral matrix protein VP40 of Ebola virus. Mol Biol Rep 2019,46(3),3315-3324","journal-title":"Mol Biol Rep"},{"key":"ref=7","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8427042","volume":"2019","author":"Nagarajan N.","year":"2019","unstructured":"Nagarajan N.; Yapp E.K.Y.; Le N.Q.K.; Kamaraj B.; Al-Subaie A.M.; Yeh H.Y.; Application of computational biology and artificial intelligence technologies in cancer precision drug discovery. BioMed Res Int 2019,2019","journal-title":"BioMed Res Int"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10822-016-9988-y","volume":"31","author":"Tsui V.","year":"2017","unstructured":"Tsui V.; Ortwine D.F.; Blaney J.M.; Enabling drug discovery project decisions with integrated computational chemistry and informatics. J Comput Aided Mol Des 2017,31(3),287-291","journal-title":"J Comput Aided Mol Des"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"Kanehisa M.","year":"2017","unstructured":"Kanehisa M.; Furumichi M.; Tanabe M.; Sato Y.; Morishima K.; KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 2017,45(D1),D353-D361","journal-title":"Nucleic Acids Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/chem.201705576","volume":"24","author":"Croft R.A.","year":"2018","unstructured":"Croft R.A.; Mousseau J.J.; Choi C.; Bull J.A.; Lithium-catalyzed thiol alkylation with tertiary and secondary alcohols: synthesis of 3-sulfanyl-oxetanes as bioisosteres. Chemistry 2018,24(4),818-821","journal-title":"Chemistry"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10822-016-9997-x","volume":"31","author":"Luty B.","year":"2017","unstructured":"Luty B.; Rose P.W.; The need for scientific software engineering in the pharmaceutical industry. J Comput Aided Mol Des 2017,31(3),301-304","journal-title":"J Comput Aided Mol Des"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","volume":"26","author":"Case D.A.","year":"2005","unstructured":"Case D.A.; Cheatham T.E.; Darden T.; The Amber biomolecular simulation programs. J Comput Chem 2005,26(16),1668-1688","journal-title":"J Comput Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/ct700301q","volume":"4","author":"Hess B.","year":"2008","unstructured":"Hess B.; Kutzner C.; van der Spoel D.; Lindahl E.; GROMACS 4:Algorithms for highly efficient, Load-balanced, and scalable molecular simulation. J Chem Theory Comput 2008,4(3),435-447","journal-title":"J Chem Theory Comput"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1021\/jm0002634","volume":"44","author":"Labute P.","year":"2001","unstructured":"Labute P.; Williams C.; Feher M.; Sourial E.; Schmidt J.M.; Flexible alignment of small molecules. J Med Chem 2001,44(10),1483-1490","journal-title":"J Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"Dixon S.L.","year":"2006","unstructured":"Dixon S.L.; Smondyrev A.M.; Knoll E.H.; Rao S.N.; Shaw D.E.; Friesner R.A.; PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des 2006,20(10-11),647-671","journal-title":"J Comput Aided Mol Des"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1021\/ci025584y","volume":"43","author":"Steinbeck C.","year":"2003","unstructured":"Steinbeck C.; Han Y.; Kuhn S.; Horlacher O.; Luttmann E.; Willighagen E.; The Chemistry Development Kit (CDK): an open-source Java library for Chemo- and Bioinformatics. J Chem Inf Comput Sci 2003,43(2),493-500","journal-title":"J Chem Inf Comput Sci"},{"key":"ref=17","first-page":"287","volume":"37","author":"Burger A.","year":"1991","unstructured":"Burger A.; Isosterism and bioisosterism in drug design. Prog Drug Res 1991,37,287-371","journal-title":"Prog Drug Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"5822","DOI":"10.1021\/acs.jmedchem.7b01788","volume":"61","author":"Meanwell N.A.","year":"2018","unstructured":"Meanwell N.A.; Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design. J Med Chem 2018,61(14),5822-5880","journal-title":"J Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.2174\/092986712803341575","volume":"19","author":"Mugnaini C.","year":"2012","unstructured":"Mugnaini C.; Pasquini S.; Corelli F.; The bioisosteric concept applied to cannabinoid ligands. Curr Med Chem 2012,19(28),4794-4815","journal-title":"Curr Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.2174\/1381612821666150109122915","volume":"21","author":"Lin Y.","year":"2015","unstructured":"Lin Y.; Chen Z-Y.; Yang F.; Application of molecular imaging technologies in antitumor drug development and therapy. Curr Pharm Des 2015,21(16),2136-2146","journal-title":"Curr Pharm Des"},{"key":"ref=21","first-page":"30","author":"Barreiro E.J.","year":"2015","unstructured":"Barreiro E.J.; Fraga C.A.M.; Bioisosterism as a Strategy for Planning, Design, Molecular Modification and Optimization of Binders and Prototype Compounds. Medicinal chemistry: The molecular basis of drugs action Porto Alegre 2015,30","journal-title":"Medicinal chemistry: The molecular basis of drugs action Porto Alegre"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.3390\/molecules24213839","volume":"24","author":"Jampilek J.","year":"2019","unstructured":"Jampilek J.; Heterocycles in medicinal chemistry. Molecules 2019,24(21),3839","journal-title":"Molecules"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/biomimetics4030053","volume":"4","author":"Hevey R.","year":"2019","unstructured":"Hevey R.; Bioisosteres of carbohydrate functional groups in glycomimetic design. Biomimetics (Basel) 2019,4(3),53","journal-title":"Biomimetics (Basel)"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1021\/ja02231a009","volume":"41","author":"Langmuir I.","year":"1919","unstructured":"Langmuir I.; Isomorphism, isosterism and covalence. J Am Chem Soc 1919,41,1543-1559","journal-title":"J Am Chem Soc"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1021\/acs.jmedchem.9b00252","volume":"62","author":"Tseng C.C.","year":"2019","unstructured":"Tseng C.C.; Baillie G.; Donvito G.; The trifluoromethyl group as a bioisosteric replacement of the aliphatic nitro group in CB1 receptor positive allosteric modulators. J Med Chem 2019,62(10),5049-5062","journal-title":"J Med Chem"},{"key":"ref=26","author":"Barreiro E.J.","year":"2015","unstructured":"Barreiro E.J.; Qu\u00edmica medicinal: As bases moleculares da a\u00e7\u00e3o dos f\u00e1rmacos 2015","journal-title":"Qu\u00edmica medicinal: As bases moleculares da a\u00e7\u00e3o dos f\u00e1rmacos"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1021\/jm00394a028","volume":"30","author":"van Wijngaarden I.","year":"1987","unstructured":"van Wijngaarden I.; Kruse C.G.; van Hes R.; van der Heyden J.A.M.; Tulp M.T.; 2-Phenylpyrroles as conformationally restricted benzamide analogues. A new class of potential antipsychotics. 1. J Med Chem 1987,30(11),2099-2104","journal-title":"J Med Chem"},{"key":"ref=28","author":"Loftsson T.","year":"2014","unstructured":"Loftsson T.; Drug stability for pharmaceutical scientists 2014","journal-title":"Drug stability for pharmaceutical scientists"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"Meng X-Y.","year":"2011","unstructured":"Meng X-Y.; Zhang H-X.; Mezei M.; Cui M.; Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 2011,7(2),146-157","journal-title":"Curr Comput Aided Drug Des"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1021\/ja01573a087","volume":"79","author":"Duschinsky R.","year":"1957","unstructured":"Duschinsky R.; Pleven E.; Heidelberger C.; The synthesis of 5- fluoropyrimidines. J Am Chem Soc 1957,79,4559-4560","journal-title":"J Am Chem Soc"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.2174\/156802606777951073","volume":"6","author":"Kirk K.L.","year":"2006","unstructured":"Kirk K.L.; Selective fluorination in drug design and development: an overview of biochemical rationales. Curr Top Med Chem 2006,6(14),1447-1456","journal-title":"Curr Top Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/179663a0","volume":"179","author":"Heidelberger C.","year":"1957","unstructured":"Heidelberger C.; Chaudhuri N.K.; Danneberg P.; Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 1957,179(4561),663-666","journal-title":"Nature"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1021\/jm00387a017","volume":"30","author":"Binder D.","year":"1987","unstructured":"Binder D.; Hromatka O.; Geissler F.; Analogues and derivatives of tenoxicam. 1. Synthesis and antiinflammatory activity of analogues with different residues on the ring nitrogen and the amide nitrogen. J Med Chem 1987,30(4),678-682","journal-title":"J Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/1568026013395335","volume":"1","author":"Ruetsch Y.A.","year":"2001","unstructured":"Ruetsch Y.A.; B\u00f6ni T.; Borgeat A.; From cocaine to ropivacaine: the history of local anesthetic drugs. Curr Top Med Chem 2001,1(3),175-182","journal-title":"Curr Top Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1039\/C8OB02812E","volume":"17","author":"Mykhailiuk P.K.","year":"2019","unstructured":"Mykhailiuk P.K.; Saturated bioisosteres of benzene: where to go next? Org Biomol Chem 2019,17(11),2839-2849","journal-title":"Org Biomol Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0960-894X(01)00134-2","volume":"11","author":"Lin P.","year":"2001","unstructured":"Lin P.; Marino D.; Lo J.L.; 2-(3,5-Dimethylphenyl)tryptamine derivatives that bind to the GnRH receptor. Bioorg Med Chem Lett 2001,11(8),1073-1076","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1021\/jm0201520","volume":"45","author":"Kim K.S.","year":"2002","unstructured":"Kim K.S.; Kimball S.D.; Misra R.N.; Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities. J Med Chem 2002,45(18),3905-3927","journal-title":"J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/0006-291X(89)91780-4","volume":"164","author":"Swapna G.V.T.","year":"1989","unstructured":"Swapna G.V.T.; Jagannadh B.; Gurjar M.K.; Kunwar A.C.; NMR investigation on the structure and conformation of 3\u2032-azido-2\u2032,3\u2032-dideoxyribosylthymine (AZT), an inhibitor of the HIV (AIDS virus). Biochem Biophys Res Commun 1989,164(3),1086-1092","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1080\/07391102.2016.1176603","volume":"35","author":"Vital D.G.","year":"2017","unstructured":"Vital D.G.; Damasceno F.S.; Rapado L.N.; Application of bioisosterism in design of the semicarbazone derivatives as cruzain inhibitors: a theoretical and experimental study. J Biomol Struct Dyn 2017,35(6),1244-1259","journal-title":"J Biomol Struct Dyn"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"10990","DOI":"10.1002\/anie.201905452","volume":"58","author":"Bentler P.","year":"2019","unstructured":"Bentler P.; Bergander K.; Daniliuc C.G.; Inverting small molecule-protein recognition by the fluorine Gauche effect: Selectivity regulated by multiple H\u2192F bioisosterism. Angew Chem Int Ed Engl 2019,58(32),10990-10994","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201800290","volume":"352","author":"Ramu D.","year":"2019","unstructured":"Ramu D.; Jain R.; Kumar R.R.; Design and synthesis of imidazolidinone derivatives as potent anti-leishmanial agents by bioisosterism. Arch Pharm (Weinheim) 2019,352(4)","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"4837","DOI":"10.1021\/acs.jmedchem.0c00117","volume":"63","author":"Kang D.","year":"2020","unstructured":"Kang D.; Feng D.; Sun Y.; Structure-based bioisosterism Yields HIV-1 NNRTIs with improved drug-resistance profiles and favorable pharmacokinetic properties. J Med Chem 2020,63(9),4837-4848","journal-title":"J Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/bjc.2014.83","volume":"110","author":"Khanim F.","year":"2014","unstructured":"Khanim F.; Davies N.; Veli\u00e7a P.; Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate. Br J Cancer 2014,110(6),1506-1516","journal-title":"Br J Cancer"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cbpa.2017.03.017","volume":"38","author":"Liu R.","year":"2017","unstructured":"Liu R.; Li X.; Lam K.S.; Combinatorial chemistry in drug discovery. Curr Opin Chem Biol 2017,38,117-126","journal-title":"Curr Opin Chem Biol"},{"key":"ref=45","first-page":"335","volume":"44B","author":"Pandeya S.N.","year":"2005","unstructured":"Pandeya S.N.; Thakkar D.; Combinatorial chemistry: A novel method in drug discovery and its application. Indian J Chem Nova Deli 2005,44B,335-348","journal-title":"Indian J Chem Nova Deli"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd839","volume":"1","author":"Capdeville R.","year":"2002","unstructured":"Capdeville R.; Buchdunger E.; Zimmermann J.; Matter A.; Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 2002,1(7),493-502","journal-title":"Nat Rev Drug Discov"},{"key":"ref=47","author":"Barreiro E.J.","year":"2008","unstructured":"Barreiro E.J.; Fraga C.A.M.; Qu\u00edmica Medicinal: As bases moleculares da a\u00e7\u00e3o dos f\u00e1rmacos 2 2008","journal-title":"Qu\u00edmica Medicinal: As bases moleculares da a\u00e7\u00e3o dos f\u00e1rmacos 2"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1021\/jm0201520","volume":"45","author":"Kim K.S.","year":"2002","unstructured":"Kim K.S.; Kimball S.D.; Misra R.N.; Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities. J Med Chem 2002,45(18),3905-3927","journal-title":"J Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"D1137","DOI":"10.1093\/nar\/gks1059","volume":"41","author":"Wirth M.","year":"2013","unstructured":"Wirth M.; Zoete V.; Michielin O.; Sauer W.H.B.; SwissBioisostere: a database of molecular replacements for ligand design. Nucleic Acids Res 2013,41(Database issue),D1137-D1143","journal-title":"Nucleic Acids Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13321-017-0251-x","volume":"9","author":"Le\u0161nik S.","year":"2017","unstructured":"Le\u0161nik S.; \u0160krlj B.; Er\u017een N.; BoBER: web interface to the base of bioisosterically exchangeable replacements. J Cheminform 2017,9(1),62","journal-title":"J Cheminform"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/jcc.25581","volume":"39","author":"Elias T.C.","year":"2018","unstructured":"Elias T.C.; de Oliveira H.C.B.; da Silveira N.J.F.; MB-Isoster: A software for bioisosterism simulation. J Comput Chem 2018,39(29),2481-2487","journal-title":"J Comput Chem"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2174\/1573409915666190704093400","volume":"16","author":"Shan J.","year":"2020","unstructured":"Shan J.; Ji C.; MolOpt: a web server for drug design using bioisosteric transformation. Curr Comput Aided Drug Des 2020,16(4),460-466","journal-title":"Curr Comput Aided Drug Des"},{"key":"ref=53","first-page":"40","author":"Gaulton A.","year":"2011","unstructured":"Gaulton A.; Bellis L.J.; Bento A.P.; ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Res 2011,40","journal-title":"Nucleic Acids Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"Morris G.M.","year":"2009","unstructured":"Morris G.M.; Huey R.; Lindstrom W.; AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009,30(16),2785-2791","journal-title":"J Comput Chem"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2010","unstructured":"Trott O.; Olson A.J.; AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010,31(2),455-461","journal-title":"J Comput Chem"},{"key":"ref=56","first-page":"715","volume":"29","author":"Coelho C.M.","year":"2018","unstructured":"Coelho C.M.; Santos T.; Freitas P.G.; Design, synthesis, biological evaluation and molecular modeling studies of novel eugenol esters as leishmanicidal agents. J Braz Chem Soc 2018,29,715-728","journal-title":"J Braz Chem Soc"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"515","DOI":"10.21577\/0103-5053.20170164","volume":"29","author":"Freitas P.G.","year":"2018","unstructured":"Freitas P.G.; Castilho T.E.; Almeida L.; An in silico study of Benzophenone derivatives as potential non-competitive inhibitors of trypanosoma cruzi and leishmania amazonensis cysteine proteinases. J Braz Chem Soc 2018,29(3),515-527","journal-title":"J Braz Chem Soc"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/database\/baw026","volume":"2016","author":"Henrique T.","year":"2016","unstructured":"Henrique T.; Jos\u00e9 Freitas da Silveira N.; Henrique Cunha Volpato A.; HNdb: an integrated database of gene and protein information on head and neck squamous cell carcinoma. Database (Oxford) 2016,2016,1-11","journal-title":"Database (Oxford)"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1089\/cmb.2019.0311","volume":"27","author":"Alves Pinto I.","year":"2020","unstructured":"Alves Pinto I.; Freitas Da Silveira N.J.; In silico identification of potential inhibitors of the wnt signaling pathway in human breast cancer. J Comput Biol 2020,27(7),999-1010","journal-title":"J Comput Biol"}],"container-title":["Current Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574893616666210525150747","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/193575\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574893616666210525150747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T05:14:08Z","timestamp":1699074848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/193575\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574893616666210525150747","relation":{},"ISSN":["1574-8936"],"issn-type":[{"type":"print","value":"1574-8936"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-11-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}